Please login to the form below

Not currently logged in

Sun Pharmaceutical Industries

This page shows the latest Sun Pharmaceutical Industries news and features for those working in and with pharma, biotech and healthcare.

Merck and Sun Pharma part company on branded generics

Merck and Sun Pharma part company on branded generics

Will continue partnership on diabetes and inflammatory disorder projects. Merck &Co and India's Sun Pharmaceutical Industries have agreed to dissolve a joint venture set up in 2011 to develop and ... Sun acquired global rights to tildrakizumab (MK-3222)

Latest news

  • Sun Pharma recalls antidepressant in US Sun Pharma recalls antidepressant in US

    Withdraws more than 40, 000 bottles of venlafaxine hydrochloride. India-based Sun Pharmaceutical Industries is to recall more than 40, 000 bottles of an antidepressant after the drug was discovered to ... This is the latest in a series of setbacks for

  • Pfizer sales dip as net income surges in Q2 Pfizer sales dip as net income surges in Q2

    from the spin-out of Zoetis and a litigation settlement with Teva and Sun Pharmaceutical Industries for patent infringement of Protonix (pantoprazole) fell 5 per cent.

  • MSD forms joint venture with Sun Pharma

    MSD (known as Merck in the US and Canada) has entered into a joint venture with India's Sun Pharmaceutical Industries to develop, manufacture and commercialise new combinations and formulations of ... The company has a proven track record in innovative

  • Thin on the ground

    Rheumatoid arthritis. Europe. Rivastigmine. Watson Pharmaceuticals. Dementia. US. Rivastigmine. Sun Pharmaceutical Industries. ... Lysteda (Ferring Pharmaceuticals). Cyclic heavy menstrual bleeding. US. Venlafaxine. Teva Pharmaceutical Industries.

  • Taro shareholders' meeting postponed

    US-headquartered Taro Pharmaceutical Industries has postponed its proposed shareholder meeting on 25 September, which was to discuss the proposed merger with India's Sun Pharmaceutical Industries. ... India's largest pharmaceutical company, Sun

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    April also saw Sun Pharmaceutical Industries relieving Daiichi Sankyo (63.9% owner) of the troubled Ranbaxy Laboratories to create India's largest pharma company, leading in 13 speciality segments, with estimated ... is rumoured that a solution will be

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...